USCB Financial Holdings, Inc. (USCB) Key Metrics
USCB valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $412.9M
- Enterprise value
- $587.6M
- P/E (TTM)
- 14.3 10-yr median 14.3
- Forward P/E
- 11.5
- PEG ratio
- —
- Price / sales
- 4.4 10-yr median 2.4
- Price / book
- 1.8 10-yr median 1.3
- EV / EBITDA
- — 10-yr median 9.1
- Dividend yield
- 2.15% $0.48 a year
- Beta
- 0.44
USCB key metrics, 2019–2025
Fiscal year ended December 31, 2025 · U.S. dollarsUSCB valuation Price multiples at each fiscal year-end price.
USCB returns How much profit the business earns on the capital it uses.
USCB per-share figures Results divided by the shares outstanding at year-end.
USCB financial health Debt, liquidity and how easily interest is covered.
USCB efficiency & capital use Working capital cycle and where the cash goes.
USCB valuation history
USCB returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
USCB debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
USCB cash returned to shareholders
USCB price vs earnings per share
USCB key metrics
2019–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Valuation | |||||||
| Market capitalization | $338.0M | $352.0M | $241.2M | $246.2M | $274.0M | — | — |
| Enterprise value | $346.4M | $229.2M | $165.2M | $252.4M | $278.0M | — | — |
| P/E ratio | 12.9 | 14.3 | 14.6 | 12.2 | 48.5 | — | — |
| Price / sales | 2.2 | 2.4 | 2.2 | 3.2 | 18.2 | — | — |
| Price / book | 1.6 | 1.6 | 1.3 | 1.3 | 1.3 | — | — |
| Price / free cash flow | 8.0 | 10.4 | 10.8 | 8.5 | 12.8 | — | — |
| Price / operating cash flow | 7.9 | 10.3 | 10.7 | 8.3 | 12.4 | — | — |
| EV / sales | 2.3 | 1.6 | 1.5 | 3.3 | 18.5 | — | — |
| EV / EBITDA | 9.5 | 6.9 | 7.4 | 9.1 | 33.0 | — | — |
| EV / free cash flow | 8.2 | 6.8 | 7.4 | 8.7 | 13.0 | — | — |
| Earnings yield | 7.7% | 7.0% | 6.9% | 8.2% | 2.1% | — | — |
| Free cash flow yield | 12.6% | 9.6% | 9.3% | 11.7% | 7.8% | — | — |
| Dividend yield | 2.3% | 1.1% | 207.4% | 0.0% | 0.8% | — | — |
| Shareholder yield (dividends + buybacks) | 12.5% | 1.3% | 210.5% | 0.0% | 7.7% | — | — |
| Share price at fiscal year-end | $18.42 | $17.75 | $12.25 | $12.20 | $14.01 | — | — |
| Per share | |||||||
| Revenue per share | $8.29 | $7.26 | $5.51 | $3.77 | $0.77 | $3.03 | $4.45 |
| Earnings per share | $1.42 | $1.24 | $0.84 | $1.00 | $0.29 | $0.56 | $1.03 |
| Operating cash flow per share | $2.33 | $1.72 | $1.15 | $1.46 | $1.13 | $0.68 | $1.42 |
| Free cash flow per share | $2.32 | $1.70 | $1.14 | $1.43 | $1.09 | $0.66 | $1.34 |
| Cash per share | $4.49 | $14.84 | $13.73 | $2.68 | $2.36 | $2.46 | $3.55 |
| Book value per share | $11.58 | $10.86 | $9.75 | $9.04 | $10.42 | $8.82 | $15.93 |
| Tangible book value per share | $11.58 | $10.86 | $9.75 | $9.04 | $10.42 | $8.82 | $15.93 |
| Dividends per share | $0.43 | $0.20 | $25.41 | $0.00 | $0.11 | $0.16 | $0.18 |
| Capex per share | $0.02 | $0.02 | $0.01 | $0.03 | $0.03 | $0.02 | $0.09 |
| Debt per share | $4.95 | $8.65 | $9.88 | $2.99 | $2.56 | $2.61 | $4.08 |
| Shares outstanding | 18.3M | 19.8M | 19.7M | 20.2M | 19.6M | 19.4M | 10.1M |
| Change in shares outstanding | −7.5% | +0.7% | −2.4% | +3.1% | +0.9% | +92.7% | — |
| Returns & profitability | |||||||
| Return on equity (ROE) | 12.2% | 12.1% | 8.8% | 10.4% | 3.0% | 6.5% | 6.5% |
| Return on invested capital (ROIC) | 16.7% | 23.7% | 10.9% | 10.2% | 3.0% | 6.4% | 6.4% |
| Return on assets (ROA) | 1.0% | 1.0% | 0.7% | 1.0% | 0.3% | 0.8% | 0.8% |
| Return on tangible assets | 0.9% | 1.0% | 0.7% | 1.0% | 0.3% | 0.7% | 0.8% |
| Free cash flow margin | 27.9% | 23.5% | 20.6% | 37.9% | 142.5% | 21.7% | 30.1% |
| Income quality (OCF / net income) | 1.64 | 1.38 | 1.36 | 1.47 | 3.90 | 1.21 | 1.38 |
| Financial health | |||||||
| Total debt | $90.7M | $171.5M | $194.4M | $60.4M | $50.2M | $50.5M | $41.0M |
| Cash & short-term investments | $82.3M | $294.2M | $270.4M | $54.2M | $46.2M | $47.7M | $35.7M |
| Net debt | $8.4M | −$122.8M | −$76.0M | $6.2M | $4.0M | $2.8M | $5.3M |
| Debt / equity | 0.43 | 0.80 | 1.01 | 0.33 | 0.25 | 0.30 | 0.26 |
| Debt / assets | 0.03 | 0.07 | 0.08 | 0.03 | 0.03 | 0.03 | 0.03 |
| Net debt / EBITDA | 0.23 | −3.71 | −3.39 | 0.22 | 0.47 | 0.19 | 0.15 |
| Current ratio | 0.03 | 0.14 | 0.14 | 0.03 | 0.03 | 0.04 | 80.14 |
| Quick ratio | 0.03 | 0.14 | 0.17 | 0.07 | 0.07 | 0.08 | 80.14 |
| Interest coverage | 0.6 | 0.5 | 0.5 | 3.6 | 7.7 | 1.5 | — |
| Working capital | −$2.42B | −$1.91B | −$1.68B | −$1.78B | −$1.55B | −$1.23B | $35.3M |
| Invested capital | $220.8M | $92.6M | $116.0M | $188.7M | $207.9M | $173.8M | $165.5M |
| Tangible asset value | $212.4M | $215.4M | $192.0M | $182.4M | $203.9M | $171.0M | $160.3M |
| Net current asset value | −$2.51B | −$2.06B | −$1.87B | −$1.84B | −$1.60B | −$1.28B | −$1.12B |
| Graham number | $19.25 | $17.44 | $13.58 | $14.25 | $8.23 | $10.53 | $19.24 |
| Graham net-net per share | −$136.05 | −$104.05 | −$96.23 | −$92.90 | −$83.07 | −$67.35 | −$110.96 |
| Capital allocation | |||||||
| Dividends paid | $7.8M | $3.9M | $500.2M | $0 | $2.1M | $3.1M | $1.8M |
| Share buybacks (net) | $34.6M | $501,000 | $7.6M | $0 | $18.9M | $7.5M | — |
| Dividend payout ratio | 30.0% | 16.0% | — | 0.0% | 36.8% | 28.9% | 17.6% |
| Dividends + buybacks / free cash flow | 99.7% | 13.1% | — | 0.0% | 98.0% | 83.3% | 13.6% |
| Capex / revenue | 0.2% | 0.2% | 0.2% | 0.9% | 4.2% | 0.6% | 1.9% |
| Capex / operating cash flow | 0.7% | 0.9% | 0.7% | 2.3% | 2.9% | 2.6% | 6.1% |
| Capex / depreciation | 0.49 | 0.53 | 0.28 | 0.98 | 0.61 | 0.27 | 0.71 |
| Stock-based compensation / revenue | 2.0% | 1.5% | 0.9% | 0.7% | 1.9% | 0.3% | 0.5% |
| SG&A / revenue | 25.9% | 20.0% | 22.5% | 31.4% | 157.6% | 36.5% | 55.7% |
| Efficiency | |||||||
| Days sales outstanding | 27.1 | 27.4 | 30.7 | 32.4 | 139.9 | 34.5 | — |
| Days of inventory on hand | — | — | -462.0 | -2,092.8 | -4,734.6 | -1,582.9 | — |
| Days payables outstanding | 7,089.6 | 101.8 | 119.3 | 426.4 | 731.8 | 15,217.5 | — |
| Cash conversion cycle (days) | -7,062.5 | -74.3 | -550.6 | -2,486.8 | -5,326.5 | -16,765.9 | — |
| Receivables turnover | 13.45 | 13.31 | 11.89 | 11.27 | 2.61 | 10.59 | — |
| Payables turnover | 0.05 | 3.59 | 3.06 | 0.86 | 0.50 | 0.02 | 0.00 |
| Asset turnover | 0.06 | 0.06 | 0.05 | 0.04 | 0.01 | 0.04 | 0.03 |
| Average receivables | $11.3M | $10.8M | $9.1M | $6.8M | $5.8M | $5.5M | — |
| Average payables | $1.24B | $18.0M | $14.6M | $11.6M | $8.2M | $512.2M | $1.02B |
| Average inventory | — | — | −$56.7M | −$57.0M | −$52.7M | −$53.3M | — |
| Intangibles / total assets | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Computed from USCB's annual financial statements (latest annual report filed March 13, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
USCB valuation and financial ratios
At the end of fiscal 2025 (December 31, 2025), USCB Financial traded at 12.9 times earnings, against a 7-year median of 14.3. Based on the latest twelve months, the trailing P/E is 14.3 and the forward P/E is 11.5. USCB Financial earned a return on equity of 12.2% and a return on invested capital of 16.7% in fiscal 2025. It ended the year with $90.7 million of debt and $82.3 million in cash and short-term investments, net debt of $8.4 million. It returned $42.4 million to shareholders: $7.8 million in dividends and $34.6 million in share buybacks, 100% of free cash flow. The share count rose 82.4% from 10.1M to 18.3M over 6 years.
See the USCB income statement, the USCB chart for price history, or the USCB stock overview for the latest quote and news.
USCB key metrics FAQ
What is USCB Financial's P/E ratio?
USCB Financial's trailing P/E ratio is 14.3 based on the last twelve months of earnings (as of October 18, 2026), and its forward P/E is 11.5. At the end of fiscal 2025 it was 12.9, compared with a 7-year median of 14.3.
What is USCB Financial's EV/EBITDA?
USCB Financial's enterprise value was 9.5 times EBITDA at the end of fiscal 2025 (enterprise value $346.4 million, EBITDA $36.5 million).
What is USCB Financial's return on equity?
USCB Financial's return on equity (ROE) was 12.2% in fiscal 2025: net income of $26.1 million on average shareholders' equity of $213.9 million.
What is USCB Financial's ROIC?
USCB Financial's return on invested capital was 16.7% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does USCB Financial have?
USCB Financial had total debt of $90.7 million at the end of fiscal 2025, a debt-to-equity ratio of 0.43 and $8.4 million of net debt (0.23 times EBITDA).
What is USCB Financial's dividend yield?
USCB Financial's forward dividend yield is 2.15%. USCB Financial paid $7.8 million in dividends in fiscal 2025 ($0.43 per share), a payout ratio of 30.0%.
Does USCB Financial buy back its shares?
Yes. USCB Financial spent $34.6 million on net share repurchases in fiscal 2025 Shares outstanding changed −7.5% over the year, to 18.3M..
What is USCB Financial's free cash flow yield?
USCB Financial generated $42.5 million of free cash flow in fiscal 2025, a free cash flow yield of 12.6% on its market value at year-end ($338.0 million).
What is USCB Financial's current ratio?
USCB Financial's current ratio was 0.03 at the end of fiscal 2025: current assets were 0.03 times current liabilities.